Antiarrhythmics: Difference between revisions

(Text replacement - "beta blocker" to "β-blocker")
 
(11 intermediate revisions by 4 users not shown)
Line 1: Line 1:
== Table ==
==Table==


{| class="wikitable" style="width: 641px; height: 711px;"
{| class="wikitable" style="width: 641px; height: 711px;"
Line 41: Line 41:
|  
|  
|  
|  
*Flecainide  
*[[Flecainide]]
*Propafenone  
*Propafenone  
*Moricizine
*Moricizine
Line 53: Line 53:
|-
|-
! II  
! II  
| Beta-blockers  
| [[Beta-blockers]]
|  
|  
*Propranolol  
*Propranolol  
*[[Esmolol]]  
*[[Esmolol]]  
*Timolol  
*Timolol  
*Metoprolol  
*[[Metoprolol]]
*Atenolol  
*[[Atenolol]]
*Bisoprolol  
*Bisoprolol  
*[[Labetalol]]
*[[Labetalol]]
Line 82: Line 82:
K<sup>+</sup> channel blocker  
K<sup>+</sup> channel blocker  


Sotalol is also a beta blocker  
Sotalol is also a β-blocker  


Amiodarone has Class I, II, and III activity  
Amiodarone has Class I, II, and III activity  
Line 115: Line 115:
Used in supraventricular arrhythmias,  
Used in supraventricular arrhythmias,  


Or in the case of [[magnesium sulfate]], used in [[Torsade de Pointe]].  
Or in the case of [[magnesium sulfate]], used in [[torsade de pointes]].  


|}
|}
Line 124: Line 124:
*[[Isoproterenol]]
*[[Isoproterenol]]


== Source  ==
==References==
*Tintinalli
<references/>
*Katzung &amp; Trevor's Pharmacology
*Katzung &amp; Trevor's Pharmacology


[[Category:Drugs]] [[Category:Cards]]
[[Category:Pharmacology]] [[Category:Cardiology]]

Latest revision as of 18:13, 14 August 2017

Table

Class Known as Examples Mechanism Clinical uses
Ia fast-channel blockers-Affect QRS complex (Na+) channel block (intermediate association/dissociation)
  • Ventricular arrhythmias
  • prevention of paroxysmal Recurrent atrial fibrillation (triggered by Vagus nerve overactivity)
  • procainamide in Wolf Parkinson White (WPW)
Ib- Do not affect QRS complex (Na+) channel block (fast association/dissociation)
  • treatment and prevention during and immediately after Myocardial infarction, though this practice is now discouraged given the increased risk of Asystole
  • Ventricular tachycardia
  • Atrial fibrillation
Ic (Na+) channel block (slow association/dissociation)
  • prevents Paroxysmal atrial fibrillation
  • treats Recurrent tachyarrhythmias of abnormal conduction system.
  • contraindicated immediately post-myocardial infarction.
II Beta-blockers beta blocking
Propranolol also shows some class I action
  • decrease Myocardial infarction mortality
  • prevent recurrence of Tachyarrhythmias
III

K+ channel blocker

Sotalol is also a β-blocker

Amiodarone has Class I, II, and III activity

IV slow-channel blockers Ca2+ channel blocker
  • prevent recurrence of Paroxysmal supraventricular tachycardia
  • reduce Ventricular rate in patients with Atrial fibrillation
V Work by other or unknown mechanisms (Direct nodal inhibition).

Used in supraventricular arrhythmias,

Or in the case of magnesium sulfate, used in torsade de pointes.

See Also

References


  • Katzung & Trevor's Pharmacology